Neurocrine Biosciences, Inc. (NBIX)

NASDAQ: NBIX · Real-Time Price · USD

157.21

-1.21 (-0.76%)

At close: May 18, 2026, 4:00 PM EDT

157.51

+0.30 (0.19%)

Pre-market: May 19, 2026, 6:52 AM EDT

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2013	FY 2012
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
INGREZZA Revenue	2.63B	2.51B	2.31B
INGREZZA Revenue Growth	4.44%	8.65%	26.01%
CRENESSITY Revenue	440.00M	301.20M	1.70M
CRENESSITY Revenue Growth	46.08%	17617.65%	-
ONGENTYS and Other Product Revenue	15.80M	19.00M	15.40M
ONGENTYS and Other Product Revenue Growth	-16.84%	23.38%	-37.40%
Total Net Product Revenue	3.08B	2.83B	2.33B
Total Net Product Revenue Growth	8.73%	21.59%	25.26%
Royalties Revenue	-	-	18.60M
Royalties Revenue Growth	-	-	-12.26%
Collaboration and Other Revenue	-	-	6.10M
Collaboration and Other Revenue Growth	-	-	15.09%
Total Collaboration Revenue	21.20M	26.60M	24.70M
Total Collaboration Revenue Growth	-20.30%	7.69%	-6.79%
Revenue (Other)	-440.00M	-301.20M	-1.70M
Revenue (Total)	3.10B	2.86B	2.36B
Revenue (Total) Growth	8.46%	21.45%	24.81%

Updated May 5, 2026. Data Source: Fiscal.ai.